Browsing publications by Professor Alan Boddy

Newcastle AuthorsTitleYear
Dr Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.		Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Christopher Hill
Dr David Jamieson
Huw Thomas
Dr Colin Brown
Professor Alan Boddy
et al.		Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo2013
Professor Alan Boddy
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years2013
Dr Gareth Veal
Professor Alan Boddy
Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoring2012
Dr Gareth Veal
Professor Alan Boddy
Chemotherapy in newborns and preterm babies2012
Professor Alan Boddy
Minimization of the Preanalytical Error in Pharmacokinetic Analyses and Therapeutic Drug Monitoring: Focus on IV Drug Administration2012
Dr Emma Meczes
Huw Thomas
Professor Richard Edmondson
Dr Gareth Veal
Professor Alan Boddy
et al.		Therapy induced carboplatin-DNA adduct levels in human ovarian tumours in relation to assessment of adduct measurement in mouse tumours2012
Professor Ruth Plummer
Professor Alan Boddy
Julieann Sludden
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours2011
Professor Alan Boddy
Professor Ann Daly
Dr Gareth Veal
Characterisation of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases2011
Dr David Jamieson
Professor Alan Boddy
Pharmacogenetics of genes across the doxorubicin pathway2011
12345678910111213141516